Jazz Pharmaceuticals: High Uncertainty, Low Risk
Jazz Pharmaceuticals is a specialty pharma company that fits the investment pattern of "high uncertainty with low risk." ...
FDA approves Azurity Pharmaceuticals’ Danziten for CML treatment
The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...